Quantitative proteomic analysis of mouse liver response to the peroxisome proliferator diethylhexylphthalate (DEHP)

Archives of Toxicology

Volumn 75, Issue 7, 2001, Pages 415-424

  Macdonald, Neil ^a   Chevalier, Stephan ^a,c   Tonge, Robert ^b   Davison, Matthew ^b   Rowlinson, Rachel ^b   Young, Janice ^b   Rayner, Steve ^b   Roberts, Ruth ^a  

^a JEALOTT S HILL INTERNATIONAL RESEARCH CENTRE   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

^c PFIZER INC   (United States)

Author keywords

Diethylhexylphthalate; Liver; Peroxisome proliferator; Peroxisome proliferator activated receptor ; Phthalate; Proteome; Proteomics

Indexed keywords

ACYL COENZYME A OXIDASE; BINDING PROTEIN; BIOLOGICAL MARKER; CARRIER PROTEIN; CYCLIN D; CYCLIN E; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PIRINIXIC ACID; PROTEOME;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOENERGY; CARBOHYDRATE METABOLISM; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME METABOLISM; ENZYME REGULATION; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GEL ELECTROPHORESIS; LIPID METABOLISM; LIVER TUMOR; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STRESS;

ANIMALS; BLOTTING, WESTERN; DIETHYLHEXYL PHTHALATE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; LIVER; MALE; MICE; MICE, KNOCKOUT; PEROXISOME PROLIFERATORS; PEROXISOMES; PROTEOME; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSCRIPTION FACTORS;

ANIMALIA; MUS MUSCULUS; RODENTIA;

EID: 0034802710     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002040100259     Document Type: Article

References (42)

1. A comparison of selected mRNA and protein abundances in human liver
2. Mechanistically-based human hazard assessment of peroxisome-proliferator-induced hepatocarcinogenesis
3. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-α in humans - No alteration in adipose tissue of obese and NIDDM patients
4. Regulation of gene expression by fatty acids and fibric acid derivatives: An integrative role for PPARs
5. Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferatoractivated receptor-α dependent
6. Fatty acid activation of peroxisome proliferator-activated receptor (PPAR)
7. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, beta and gamma in the adult rat
8. Peroxisome proliferator-activated receptor α-null mice lack resistance to acetaminophen hepatotoxicity following clofibrate exposure
9. G1-arrested FaO cells re-enter the cell cycle upon stimulation with the rodent nongenotoxic hepatocarcinogen nafenopin
10. Stimulation de la croissance hépatocytaire par les proliférateurs de peroxysomes
11. Induction of DNA replication by peroxisome proliferators is independent of both TNFα priming and EGF-receptor tyrosine kinase activity
12. Proteomic analysis of differential protein expression in primary hepatocytes induced by EGF, TNFα or the peroxisome proliferator, nafenopin
13. The application of genomics and proteomics to toxicological sciences
14. 4 pathway to inflammation control
15. A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY14,643
16. Phytanic acid activates the peroxisome proliferator-activated receptor α (PPARα) in sterol carrier protein 2-/ sterol carrier protein x-deficient mice
17. PPARs: Insight into multiple cellular functions
18. Purification, molecular cloning, and expression of 2-hydroxyphytanoyl-CoA lyase, a peroxisomal thiamine pyrophosphate-dependent enzyme that catalyzes the carbon-carbon bond cleavage during α-oxidation of 3-methyl-branched fatty acids
19. Core I protein of bovine ubiquinol-cytochrome-c reductase; an additional member of the mitochondrial-protein-processing family. Cloning of bovine core I and core II cDNAs and primary structure of the proteins
20. Mouse liver selenium-binding protein decreased in abundance by peroxisome proliferators
21. Mechanism of action of the nongenotoxic peroxisome proliferators: Role of the peroxisome proliferator activated receptor α
22. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
23. An in vitro model of rodent hepatocarcinogenesis
24. Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor α by phosphorylation of a ligand-independent trans-activating domain
25. Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting
26. PPARα controls the hepatic CYP4A induction adaptive response to starvation and diabetes
27. Studies on the hepatic effects of orally administered DEHP in the rat
28. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleitrophic effects of peroxisome proliferators
29. PPARα-dependent alteration of GRP94 expression in mouse hepatocytes
30. Peroxisome proliferation and non-genotoxic carcinogenesis: Commentary on a symposium
31. Peroxisome proliferator activated receptor α expression in human liver
32. Role of PPARα in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643
33. Role of peroxisome proliferator-activated receptor α in altered cell cycle regulation in mouse liver
34. Modulation of rat liver apolipoprotein gene expression and serum lipid levels by tetradecylthioacetic acid (TTA) via PPARα activation
35. Malignant tumors in rats fed nafenopin, a hepatic peroxisome proliferator
36. Peroxisome proliferators: Mechanisms of adverse rodents effects and molecular basis for species differences
37. Role of the peroxisome proliferator activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression
38. Proteomics to display lovastatin-induced protein and pathway regulation in liver
39. Validation and development of fluorescence two-dimensional differenential gel electrophoresis proteomics technology
40. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl-CoA oxidase gene
41. A PPAR-α cDNA cloned from guinea pig liver encodes a protein with similar properties to the mouse PPARα: Implications for species differences in response to peroxisome proliferators
42. Extraperoxisomal targets of peroxisome proliferators: Mitochondrial, microsomal and cytosolic effects. Implications for health and disease